Presentation of principles and methodologies for various clinical trials, and a well-balanced summary of current regulatory requirements. Emphasizes real-life examples and illustrations from clinical case studies, as well as numerous references.
"269" Result
Sort By:
This text details essential components of performing simulation for designing clinical trials via pharmacokinetic-pharmacodynamic modelling. It offers a range of applications for optimizing sampling strategies, selecting dosage and predicting drug efficacy and side-effects.
This book examines the background, construction, evaluation, and execution of simulation models for optimizing the design of clinical trials. -- book cover.
This publication contains a verbatim reproduction of 21 CFR Part 50 Protection of Human Subjects, 21 CFR Part 54 Financial Disclosure by Clinical Investigators, 21 CFR Part 56 Institutional Review Boards and 21 CFR Part 312 Investigational New Drug Application.
(A) This part applies to all clinical investigations regulated by the Food and DrugAdministration under sections 505(i) and 520(g) of the Federal Food, Drug, and CosmeticAct, as well as clinical investigations that support applications for research or marketingpermits for produc…
(A) This part applies to all clinical investigations regulated by the Food and DrugAdministration under sections 505(i) and 520(g) of the Federal Food, Drug, and CosmeticAct, as well as clinical investigations that support applications for research or marketingpermits for produc…
